{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:47:31Z","timestamp":1772308051431,"version":"3.50.1"},"reference-count":40,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T00:00:00Z","timestamp":1234396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background and Aim:\u2002<\/jats:bold> To investigate the protective effects and the mechanism of anisodamine on deposition of extracellular matrix in experimental liver fibrosis.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Experimental liver fibrosis was produced by carbon tetrachloride (CCL<jats:sub>4<\/jats:sub>). The preventive group was treated for 10\u2003weeks with anisodamine 7.0\u2003mg\/kg per day i.p. injection. Two therapeutic groups were treated for 6\u2003weeks by anisodamine 7.0 or 14.0\u2003mg\/kg per day i.p. injection. Studies were made at CCL<jats:sub>4<\/jats:sub> administration on the 10th weekend. Serum biochemical indices and the contents of malondialdehyde (MDA) and hydroxyproline (HYP) in livers were compared. The expression of transforming growth factor\u2010\u03b21 (TGF\u2010\u03b21) was observed by immunohistochemistry. The reverse transcription polymerase chain reaction was used to detect the expressions of matrix metalloproteinase\u20102 (MMP2) and tissue inhibitor of metalloproteinase\u20102 (TIMP2) mRNA in livers and the ratio of MMP2 and TIMP2 was measured. The proteins of MMP2 in liver were determined by gelatin zymography.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The serum levels of alanine aminotransferase, aspartate aminotransferase, \u03b3\u2010glutamyltransferase and hyaluronic acid of liver fibrosis rats improved significantly by treatment with anisodamine. The contents of MDA and HYP in liver decreased and the expressions of TGF\u2010\u03b21 were inhibited by treatment with anisodamine. The levels of MMP2 and TIMP2 mRNA and the protein of MMP2 in livers were significantly reduced in the anisodamine preventive group and therapeutic groups. The expression ratios of MMP2 and TIMP2 mRNA were adjusted in treated groups.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Anisodamine can inhibit hepatic fibrosis.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2008.05756.x","type":"journal-article","created":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T06:03:57Z","timestamp":1234418637000},"page":"1070-1076","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antifibrotic activity of anisodamine <i>in vivo<\/i> is associated with changed intrahepatic levels of matrix metalloproteinase\u20102 and its inhibitor tissue inhibitors of metalloproteinases\u20102 and transforming growth factor \u03b21 in rats with carbon tetrachloride\u2010induced liver injury"],"prefix":"10.1111","volume":"24","author":[{"given":"Lin","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,5,27]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.10.203"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04659.x"},{"key":"e_1_2_6_4_2","first-page":"297","article-title":"Hepatic fibrogenesis","volume":"48","author":"Lee KS","year":"2006","journal-title":"Korean J. Gastroenterol."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2005.03.008"},{"key":"e_1_2_6_6_2","first-page":"2092","article-title":"Antifibrotic effects of interleukin\u201010 on experimental hepatic fibrosis","volume":"54","author":"Zhang LJ","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_6_7_2","first-page":"957","article-title":"Prevention of liver fibrosis by the purinoceptor antagonist pyridoxal\u2010phosphate\u20106\u2010azophenyl\u20102\u2032,4\u2032\u2010disulfonate (PPADS)","volume":"21","author":"Dranoff JA","year":"2007","journal-title":"In Vivo"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60383-9"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/jat.1154"},{"key":"e_1_2_6_10_2","first-page":"1193","article-title":"Protective effects and mechanisms of anisodamine on experimental liver injury","volume":"5","author":"Lin LUO","year":"2003","journal-title":"J. Chinese Physician"},{"key":"e_1_2_6_11_2","first-page":"1237","article-title":"Study on the therapeutic effects and prognosis of anisodamine on chronic active hepatitis B","volume":"19","author":"Xingliu W","year":"1999","journal-title":"Acta Academiae Medicinae Suzhou"},{"key":"e_1_2_6_12_2","first-page":"563","article-title":"Proteomic analysis of proliferation and apoptosis in carbon tetrachloride induced rat liver fibrosis","volume":"13","author":"Liu Y","year":"2005","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02706220"},{"key":"e_1_2_6_14_2","first-page":"1029","article-title":"Diagnostic evaluation of carbon tetrachloride\u2010induced rat hepatic cirrhosis model","volume":"25","author":"Lee GP","year":"2005","journal-title":"Anticancer Res"},{"key":"e_1_2_6_15_2","first-page":"110","article-title":"Hepatoprotective effects of setarud against carbon tetrachloride\u2010 induced liver injury in rats","volume":"27","author":"Khorshid HR","year":"2008","journal-title":"Indian J. Gastroenterol."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00185.2007"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.04867.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04700.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04361.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2007.04.002"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2007.04.016"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.2277"},{"key":"e_1_2_6_23_2","first-page":"317","article-title":"Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor\u2010beta1 in hepatofibrogenesis of a rat cirrhosis model","volume":"19","author":"Kuriyama S","year":"2007","journal-title":"Int. J. Mol. Med."},{"key":"e_1_2_6_24_2","first-page":"19","article-title":"Polaprezinc attenuates liver fibrosis in a mouse model of non\u2010alcoholic steatohepatitis","author":"Sugino H","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240211"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-007-0387-5"},{"key":"e_1_2_6_27_2","first-page":"32","article-title":"Effect of Ani on proliferation of rat hepatic satellate cell","volume":"27","author":"Zhao W\u2010L","year":"2004","journal-title":"Heilingjiang Med. Pharm."},{"key":"e_1_2_6_28_2","first-page":"51","article-title":"Activation of matrix metalloproteinase\u20102 from hepatic stellate cells requires interactions with hepatocytes","volume":"150","author":"Theret N","year":"1997","journal-title":"Am. J. Pathol."},{"key":"e_1_2_6_29_2","first-page":"583","article-title":"The anti\u2010fibrotic effect of liver growth factor is associated with decreased intrahepatic levels of matrix metalloproteinases 2 and 9 and transforming growth factor beta 1 in bile duct\u2010ligated rats","volume":"23","author":"D\u00edaz\u2010Gil JJ","year":"2008","journal-title":"Histol. Histopathol."},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04586.x"},{"key":"e_1_2_6_31_2","first-page":"267","article-title":"The role of changes of MMP\u20102, 9 activity in the development of liver fibrosis in rats","volume":"12","author":"Wang XB","year":"2004","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"e_1_2_6_32_2","first-page":"721","volume-title":"The Liver: Biology and PathoBiology","author":"Rojkind M","year":"2001"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80007-5"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01192.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M100754200"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.20521"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.1009"},{"key":"e_1_2_6_38_2","first-page":"315","article-title":"Hepatic fibrosis: role of matrix metalloproteases and TGF beta","volume":"141","author":"Sent\u00edes\u2010G\u00f3mez MD","year":"2005","journal-title":"Gac. Med. Mex."},{"key":"e_1_2_6_39_2","first-page":"601","article-title":"New hot spot of liver fibrosis therapy\u2010TIMPs","volume":"11","author":"Xie Yumei","year":"2003","journal-title":"Shi Jie Hua Ren Xiao Hua Za Zhi"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00138.x"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2005.03.008"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2008.05756.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2008.05756.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T11:32:59Z","timestamp":1697369579000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2008.05756.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,27]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1440-1746.2008.05756.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2008.05756.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,27]]},"assertion":[{"value":"2009-05-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}